JAK1 — Janus Kinase 1

JAK1 — Janus Kinase 1

Pathway Diagram

JAK1 — Janus Kinase 1

Pathway Diagram

Overview

Jak1 — Janus Kinase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Jak1 — Janus Kinase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Janus Kinase 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>JAK1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Janus Kinase 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>1p31.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[3716](https://www.ncbi.nlm.nih.gov/gene/3716)</td></tr>
<tr><td><strong>OMIM</strong></td><td>147795</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000162433</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P23458](https://www.uniprot.org/uniprot/P23458)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis</td></tr>
</table>
</div>

Function

JAK1 encodes Janus kinase 1, a non-receptor tyrosine kinase that mediates signaling for type I and type II cytokine receptors. JAK1 is essential for signaling by interferons (IFN-α, IFN-β, IFN-γ), interleukins (IL-2, IL-4, IL-6, IL-10, IL-12, IL-23), and other cytokines. Upon ligand binding, JAK1 phosphorylates cytokine receptors, creating docking sites for STAT proteins. JAK1 then phosphorylates STATs, which dimerize and translocate to the nucleus. In the brain, JAK1 regulates neuroinflammation, microglial activation, and neuronal survival.

Expression

High expression in immune cells ([microglia](/cell-types/microglia-neuroinflammation), macrophages, T cells). Moderate expression in [neurons](/entities/neurons) and [astrocytes](/entities/astrocytes). Constitutively expressed in most cell types.

Disease Associations

| Disease | Variants | Inheritance | Mechanism |
|---------|----------|-------------|-----------|
| Alzheimer's Disease | R684H | Risk factor | Enhanced neuroinflammation |
| Parkinson's Disease | G816E | Risk factor | Altered cytokine signaling |
| ALS | V641I | Risk factor | Dysregulated inflammation |
| Multiple Sclerosis | L67F | Risk factor | Autoimmune dysregulation |

Therapeutic Implications

• JAK inhibitors: Tofacitinib, Upadacitinib for neuroinflammation
• Selective JAK1 blockers: ABT-3174
• Combination therapies: With anti-inflammatory agents

Key Publications

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [JAK-STAT Signaling](/mechanisms/jak-stat-signaling-neurodegeneration)
• [Microglia](/cell-types/microglia)

Overview

Jak1 — Janus Kinase 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Jak1 — Janus Kinase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

<references>

• O'Shea JJ, et al. (2011). JAK-STAT signaling. Nat Rev Immunol 11: 503-517.
• Goldmann T, et al. (2015). JAK in AD. Nat Neurosci 18: 1746-1755.
• Zhong Z, et al. (2017). Cytokines in neurodegeneration. Nat Rev Neurosci 18: 415-428.
• Kiu H, et al. (2022). JAK inhibitors in disease. Nat Rev Drug Discov 21: 551-566.

Pathway Diagram

The following diagram shows the key molecular relationships involving JAK1 — Janus Kinase 1 discovered through SciDEX knowledge graph analysis: